MedPath

Saffron (Crocus sativus) as an adjuvant therapy for chronic schizophrenia

Phase 2
Conditions
Schizophrenia.
Schizophrenia
Registration Number
IRCT20090117001556N140
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Diagnosis of schizophrenia based on DSM-5
The score less than 14 based on HARS
Age range: 18-60 years
At least, 4 months treated with Risperidone

Exclusion Criteria

Diagnosis of another disorder in axis II
Diagnosis of a significant neurological or systemic disease, acute or chronic
History of central nervous system surgery
Treatment with ECT during the last 3 months

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of schizophrenia. Timepoint: Baseline and weeks 4 and 8. Method of measurement: By Positive and Negative Syndrome Scale (PANSS).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath